Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata.
Ana M MontillaFrancisco Gómez-GarcíaPedro J Gómez-AriasJesús Gay-MimbreraJorge Hernández-ParadaBeatriz Isla-TejeraJuan RuanoPublished in: Dermatology and therapy (2019)
Evidence on the efficacy and safety of drugs targeting the JAK/STAT pathway for the treatment of patients with AD, vitiligo, or AA is increasing but is still of low quality.